As cannabis continues to grow as a legitimate industry, the challenges around how brands market themselves have become more complex. With traditional advertising avenues off limits due to federal and ...

President Trump signed an EO last week that directs federal agencies to reschedule cannabis. The move will benefit US MSOs, including Cresco Labs, because they will be free of the 280e tax burden.

TORONTO, Dec. 19, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in precision ...

MediPharm Labs ( (TSE:LABS)) has issued an update. MediPharm Labs is positioning itself to capitalize on the U.S. decision to reclassify cannabis from Schedule I to Schedule III, a move that ...

Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), today issued a statement on behalf of Cresco Labs CEO Charlie Bachtell following President Trump’s action to ...

Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), today issued a statement on behalf of Cresco Labs CEO Charlie Bachtell following President Trump’s action to ...